SCHEMBL8229258

SCHEMBL8229258

CN(C(=O)c1cccc(Cl)c1)C1CCCN(c2nccs2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.46
PRKDC P78527 1/20 0.46
GPR142 Q7Z601 3/20 0.43
BTK Q06187 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
POLB P06746 1/20 0.40
RHOA P61586 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KDM2B Q8NHM5 3/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRM5 P41594 2/20 0.38
HSD11B1 P28845 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL973007 0.83 PRKDC (0.40) PPARAPRKDCBTKRHOAGRM5
SCHEMBL8228122 0.81 HSD17B10 (0.51) BTKALDH1A1HTT
SCHEMBL8242622 0.75 HSD17B10 (0.56) ALDH1A1HTT
SCHEMBL972892 0.74 DRD2 (0.45) PRKDCBTKL3MBTL1ALDH1A1MAPT
SCHEMBL23839836 0.74 HSD11B1 (0.58) GPR142MEN1KMT2APOLBL3MBTL1
SCHEMBL972450 0.72 GRM5 (0.39) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL23839834 0.70 GPR142 (0.50) GPR142MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL973845 0.69 HPGD (0.43) PPARABTKRHOAALDH1A1GRM5
SCHEMBL17020126 0.68 GPR142 (0.54) GPR142MEN1KMT2AMAPTHTT
SCHEMBL23716713 0.68 GPR142 (0.54) GPR142MEN1KMT2AMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7871999-B2 Substituted thiazoles and their use for producing drugs GRUENENTHAL GMBH (DE) 2011-01-18 US disclosed
US-20090176756-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-07-09 US disclosed
WO-2007079960-A9 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2008-10-23 WO disclosed
WO-2007079960-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176756-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS TPMT, SLC5A2, DPP4 PPARA 11/4885PRKDC 1624/4885GPR142 3966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.